13 Results for "

μ-receptor

" in MedChemExpress (MCE) Product Catalog:
Products (13)

13 Results for "μ-receptor" in MCE Product Catalog:

Cat. No.: HY-120613
CAS No.: 684238-37-7
Purity:  99.66%
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

BMS-986187 is an δ-opioid receptor-selective positive allosteric modulator (PAM) with an EC50 of 0.03 μM and a pKB of 6.02 (~1 μM). BMS-986187 has no observable PAM activity at the μ-receptor (EC50=3 μM) .
loading...
    loading...
Cat. No.: HY-P1701
CAS No.: 74135-04-9
Morphiceptin is a potent and specific agonist for morphine (μ) receptors. Morphiceptin, as a synthetic peptide, is the amide of a fragment of the milk protein β-casein. Morphiceptin has morphinelike activities and is highly specific for morphine (μ) receptors but not for Enkephalin receptors .
loading...
    loading...
Cat. No.: HY-141515
CAS No.: 313671-26-0
Purity:  98.89%
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

BMS-986121 is a positive allosteric modulator (PAM) of the μ opioid receptor extracted from patent WO2014107344. BMS-986121 is built on a chemical scaffold representing a new chemotype for μ receptor PAMs .
loading...
    loading...
Cat. No.: HY-106601A
CAS No.: 74685-16-8
Synonyms: LY-150720 hydrochloride
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

Picenadol (LY-150720) hydrochloride is an opioid mixed agonist-antagonist analgesic. Picenadol hydrochloride is an external racemic mixture, where its d-isomer (LY136596) is a potent μ-opioid receptor agonist, and the l-isomer (LY136595) is a weak μ-receptor competitive antagonist, which can inhibit the agonist effect and reduce the risk of dependence. Picenadol hydrochloride has anticholinergic activity .
loading...
    loading...
Cat. No.: HY-P1617
CAS No.: 105496-35-3
Target:  

Endogenous Metabolite

Research Areas:  

Neurological Disease

LY 190388 is a penicillamine-containing enkefa peptide analog with μ receptor agonist activity. LY 190388 showed analgesic effect in inhibiting the writhing response in mice after intracerebroventricular administration. The analgesic effect of LY 190388 is not caused by its δ receptor agonist action, but by its μ receptor agonist activity. When LY 190388 is used together with the δ receptor antagonist ICI 174864, an additive analgesic effect is produced .
loading...
    loading...
Cat. No.: HY-106601
CAS No.: 79201-85-7
Synonyms: LY-150720
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

Picenadol (LY-150720) is an opioid mixed agonist-antagonist analgesic. Picenadol is an external racemic mixture, where its d-isomer (LY136596) is a potent μ-opioid receptor agonist, and the l-isomer (LY136595) is a weak μ-receptor competitive antagonist, which can inhibit the agonist effect and reduce the risk of dependence. Picenadol has anticholinergic activity .
loading...
    loading...
Cat. No.: HY-101343
CAS No.: 167710-87-4
Purity:  ≥98.0%
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

RS 39604 is a potent, selective, and orally active 5-HT4 receptor antagonist with a pKi of 9.1 in guinea pig striatal membranes. RS 39604 displays a low affinity (pKi<6.5) for 5-HT1A, 5-HT2C, 5-HT3, α1c, D1, D2, M1, M2, AT1, B1 and opioid mu receptors and moderate affinity for δ1, (pKi=6.8) and δ2 (pKi=7.8) sites .
loading...
    loading...
Cat. No.: HY-182563
CAS No.: 72732-17-3
Target:  

Opioid Receptor

Research Areas:  

Endocrinology

Tyr-Ala-N-(1,3-dimethylbutyl)glycinamide is a μ/δ opioid receptor ligand with high μ opioid receptor selectivity and agonist activity. Tyr-Ala-N-(1,3-dimethylbutyl)glycinamide has an IC50 of 237 nM for μ receptors and 1050 nM for δ receptors. Tyr-Ala-N-(1,3-dimethylbutyl)glycinamide shows Ki values of 17 nM for μ receptors and 480 nM for δ receptors. Tyr-Ala-N-(1,3-dimethylbutyl)glycinamide inhibits electrically evoked contractions of guinea pig ileum and mouse vas deferens. Tyr-Ala-N-(1,3-dimethylbutyl)glycinamide serves as a starting compound for structure-activity relationship investigations of μ receptor recognition .
loading...
    loading...
Cat. No.: HY-P77363
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: FCAMR; CD351; Fc Alpha And Mu receptor; Fc receptor, IgA, IgM, High Affinity; Fc Alpha/Mu receptor; Fc Fragment Of IgA And IgM receptor; High Affinity Immunoglobulin Alpha And Immunoglobulin Mu Fc receptor; receptor For Fc Fragment Of IgA And IgM; Fcalpha
Species:  
Mouse
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P87444A
Synonyms: CD351, FKSG87, FCAMR, High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor, Fc alpha/mu receptor

Host:  

Mouse

Application:  

FC, ELISA

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P705902
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: PTPRM; receptor Protein-Tyrosine Kinase; Prev. PTPRL1; Protein-Tyrosine Phosphatase Mu; HR-PTPu; Protein-Tyrosine-Phosphatase; RPTPU; R-PTP-MU; receptor-Type Tyrosine-Protein Phosphatase Mu; R-PTP-Mu; Protein Tyrosine Phosphatase, receptor Type, Mu Polype
Species:  
Human
Source:  
Sf9 insect cells
loading...
    loading...
Cat. No.: HY-P77364
Purity:  ≥ 80%, as determined by reducing SDS-PAGE.
Synonyms: FCMR; Immunoglobulin Mu Fc receptor; Prev. FAIM3; IgM Fc receptor; TOSO; IgM FcR; Fas Apoptotic Inhibitory Molecule 3; IgM Fc Fragment receptor; FcmuR; Fc Mu R; Regulator Of Fas-Induced Apoptosis Toso; Fc Mu receptor; Fc Fragment Of IgM receptor
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-W241255
CAS No.: 27473-62-7
2-Aminoindan-2-carboxylic acid is a conformationally restricted Phenylalanine analog and molecular building block. 2-Aminoindan-2-carboxylic acid constitutes a component of allosteric LFA-1 antagonists targeting the LFA-1/ICAM-1 interaction. 2-Aminoindan-2-carboxylic acid serves as a molecular building block for various biologically active peptides, including μ-receptor-selective opioid analogs, activated protein C inhibitors, and histone deacetylase inhibitors. 2-Aminoindan-2-carboxylic acid can be used in the research of autoimmune diseases, inflammatory diseases, opioid receptor-related diseases, antidiuresis-related diseases, and cancers .
loading...
    loading...
  • 1